Overview

Effectiveness and Safety of Amisulpride in Chinese Patients With Schizophrenia

Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
Primary Objective: To evaluate the effectiveness of amisulpride in Chinese patients with schizophrenia Secondary Objective: To evaluate the overall safety of amisulpride in Chinese patients with schizophrenia.
Phase:
Phase 4
Details
Lead Sponsor:
Sanofi
Treatments:
Amisulpride
Sulpiride
Sultopride